BAY-X 1005
CAS: 128253-31-6
Ref. 3D-DFA25331
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- 2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid
- Veliflapon
- (2R)-cyclopentyl[4-(quinolin-2-ylmethoxy)phenyl]ethanoic acid
- Cyclopentyl[4-(Quinolin-2-Ylmethoxy)Phenyl]Acetic Acid
Bay-X 1005 is a nonsteroidal anti-inflammatory drug that belongs to the class of ester linkages. It is used to treat inflammatory bowel disease and other autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, and lupus erythematosus. Bay-X 1005 inhibits the production of PGE2 in inflamed tissue by blocking cyclooxygenase activity. This drug also has been shown to have an effect on cell factor (CD40) and stem cell factor (SCF), which are involved in inflammation. Bay-X 1005 binds to the cell receptor for SCF and blocks its ability to activate T cells and B cells. This leads to a decrease in inflammation by reducing the number of activated T cells that produce cytokines. The hydroxyl group on Bay-X 1005 may be responsible for this effect.
Propiedades químicas
Consulta técnica sobre: 3D-DFA25331 BAY-X 1005
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
